$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The latest market price of Zolbetuximab in 2026 and reference for drug purchase costs through different channels
2026-02-01 22:25:32
Check Details
Analysis of the main functions, side effects and clinical use precautions of EIKANCE 0.01% atropine sulfate eye drops
2026-02-01 22:25:32
Check Details
Explanation of overseas purchase channels and price of pacritinib
2026-02-01 22:25:32
Check Details
Analysis of the main functions of Letermovir (Premin) and its application in preventing infection after transplantation
2026-02-01 22:25:32
Check Details
Etrasimod tablets (Etrasimod)-Velsipity pharmacological mechanism and clinical application overview
2026-02-01 22:25:32
Check Details
Description of the risks, side effects and precautions for using Rutrombopag (Venda)
2026-02-01 22:25:32
Check Details
Analysis of Omarigliptin taking time selection and medication recommendations
2026-02-01 22:25:32
Check Details
Lecanemab-LEQEMBI domestic marketing progress and clinical use
2026-02-01 22:25:32
Check Details
Explanation of domestic drug purchase channels and formal acquisition methods of golodirsen
2026-02-01 22:25:32
Check Details
Disitamab price, dosage specifications and drug purchase reference
2026-02-01 22:25:32
Check Details
Isatuximab (Isatuximab) price, specifications and purchase channels
2026-02-01 22:25:32
Check Details
Capivasertib resistance mechanism and long-term use response plan
2026-02-01 22:25:32
Check Details
1
2
...
2389
2390
2391
2392
2393
2394
2395
...
2439
2440
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
ROS and Cancer: The Potential of Natural Antioxidants
2
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
3
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
4
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
5
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
6
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial
7
From Causes to Treatments—Exploring Medical Breakthroughs
8
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets
9
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship
10
Tyrosine Kinase and JAK Inhibitors May Increase Keratinocyte Carcinoma Risk: New Research Reveals Drug Safety Findings
11
CLISGen Database: A New Tool for Cell Line Selection in Cancer Genetic Variation Research
12
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope